2005
DOI: 10.1002/hep.20693
|View full text |Cite
|
Sign up to set email alerts
|

Tenofovir in chronic hepatitis B†

Abstract: Reply:As Dr. Russo highlights, we found serum sodium, at the date of listing for liver transplantation and at any time while on the wait list, to be strongly associated with wait-list mortality, independent of the MELD score. 1 For a serum sodium Ͻ126 mEq/L at any point while on the wait list, the lowest excess risk consistent with our results was 2.9 times that of those with higher serum sodium concentrations (hazard ratio of 6.26, 95% CI 2.92-13.4). Serum sodium as a continuous variable also had a significan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…Tenofovir has been used in subjects with cirrhosis following HBV infection13 and in HBV/HIV co-infection. Subjects who developed adefovir resistance, responded to treatment to tenofovir 12.…”
Section: Discussionmentioning
confidence: 99%
“…Tenofovir has been used in subjects with cirrhosis following HBV infection13 and in HBV/HIV co-infection. Subjects who developed adefovir resistance, responded to treatment to tenofovir 12.…”
Section: Discussionmentioning
confidence: 99%